Substance Use Clinical Trial
Official title:
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
The primary goal of this study is to test the effectiveness of the iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) curriculum, a novel drug education and diversion program, in approximately 300 middle and high school students, who have violated their school substance use policies in the past month, as an alternative to punitive school responses for school-based substance use infractions. This randomized controlled trial will test the hypothesis that adolescents randomized to the iDECIDE curriculum will have improved substance use outcomes (i.e., knowledge, attitudes, and behavior) compared to adolescents in a waitlist control group. The outcomes of this study will measure knowledge of drug effects and brain development, perceptions of harm from substance use, willingness to quit or reduce use, and substance use behavior.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | July 31, 2026 |
Est. primary completion date | September 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 22 Years |
Eligibility | Inclusion Criteria: 1. Currently enrolled in middle or high school; 2. Violated school substance use policy within approximately the past month at the time of screening; 3. Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18); 4. Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older); 5. Able to commit to 9 study visits over approximately one year; 6. Able to safely participate in the protocol and appropriate for outpatient level of care, in the opinion of the investigator; 7. Has access to a reliable internet connection and a device that can run Zoom; 8. Able to read and write comfortably in one of the languages spoken by study staff. Exclusion Criteria: 1. Ever received substance use treatment in an inpatient or specialty care setting; 2. Gross cognitive impairment, for example due to florid psychosis, intellectual disability, developmental delay, or neurodegenerative disease; 3. Ever engaged in intravenous (IV) drug use; 4. Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use. |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | Massachusetts Department of Health |
United States,
Liu J, Butler R, Turncliff A, Gray C, Lynch S, Whittaker J, Iroegbulem V, Howell D, Schuster RM. An Urgent Need for School-Based Diversion Programs for Adolescent Substance Use: A Statewide Survey of School Personnel. J Adolesc Health. 2023 Sep;73(3):428-436. doi: 10.1016/j.jadohealth.2023.04.006. Epub 2023 Jun 15. — View Citation
Schuster RM, Cather C, Pachas GN, Nielsen L, Iroegbulem V, Dufour J, Potter K, Levy S, Gray KM, Evins AE. A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol. Front Psychiatry. 2023 Mar 15;14:1083791. doi: 10.3389/fpsyt.2023.1083791. eCollection 2023. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Knowledge of Drug Effects and Brain Development | Knowledge of drug effects and brain development will be measured with a multiple choice questionnaire that assesses knowledge taught in the iDECIDE curriculum, including neurobiology of addiction, side effects of substance, and industry tactics to market substances to young audiences. | Baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) | |
Primary | Frequency of Substance Use | The Timeline Follow-Back (TLFB) will be used to measure number of days the participant used a substance, which substances were used, and the frequency of which substances were used. The initial TLFB at the baseline visit will measure substances used in the past 90 days, while the interim TLFB will measure substances used since each subsequent visit. Participants will also provide a urine sample at study visits 1, 5, 6, 7 to qualitatively screen for substances including amphetamines, cocaine, barbiturates, methamphetamines, benzodiazepines, opiates, marijuana, phencyclidine, propoxyphene, and methaqualone using a urine 10-panel. There will also be an assay to quantitate levels of cotinine and creatinine-adjusted carboxy THC at baseline, end-of-intervention, one-week follow-up, and one-month follow-up. The primary outcome will be change in frequency of past week use (number of days) for the substance used most frequently at baseline. | Baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) | |
Primary | Readiness to Quit or Reduce Substance Use | Participants will complete a Readiness Ruler to determine how ready they are to reduce their substance use on a scale from 1 (not at all ready) to 10 (very ready). | Baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) | |
Primary | Perceived Harm of Substance Use | The Perceived Harm of Substance Use measure was modified from the 2010 National Survey on Drug Use and Health. Participants will assess their perceived harm of various forms of substance use using four response categories that range from no risk to great risk. | Baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06003725 -
Cultural Adaptation of Drug Treatment for DJJ Youth
|
N/A | |
Recruiting |
NCT05414344 -
A Brief Intervention for Alcohol Users With Interpersonal Trauma
|
N/A | |
Recruiting |
NCT05768815 -
Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright
|
N/A | |
Completed |
NCT05606601 -
An Online Intervention Addressing Mental Health and Substance Use in University Students
|
N/A | |
Completed |
NCT03489434 -
Technology-Based Prevention for Adolescents in Primary Care
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT02990026 -
Specialty Mental Health Probation in North Carolina
|
N/A | |
Not yet recruiting |
NCT06116266 -
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
|
N/A | |
Not yet recruiting |
NCT03249428 -
E-Cigarette Inner City RCT
|
N/A | |
Active, not recruiting |
NCT03129334 -
Preventing Prescription Drug Abuse in Middle School Students
|
N/A | |
Completed |
NCT04183400 -
Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness
|
N/A | |
Completed |
NCT02112201 -
The ProGirls Study
|
N/A | |
Completed |
NCT01752998 -
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
|
N/A | |
Terminated |
NCT01661517 -
Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
|
Phase 0 | |
Completed |
NCT01351454 -
Behavioral Depression Treatment for African American HIV-infected Substance Users
|
N/A | |
Completed |
NCT01511380 -
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
|
Phase 2 | |
Completed |
NCT01154309 -
Group CBT for Depression and AOD Disorders
|
Phase 1 | |
Completed |
NCT00996541 -
Support To Reunite Involve and Value Each Other
|
N/A | |
Completed |
NCT01025674 -
Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8
|
N/A |